Carlsmed CARL
NASDAQ CARL
$14.10 +0.01 (+0.04%)
As of: Sep 30, 2026 · 3:12 PM EDT

Carlsmed (CARL) EBITDA (2024 - 2026)

Updated

Carlsmed's EBITDA came in at -$10.91 million for Q2 2026, compared with -$6.44 million a year earlier.

Analysis

Carlsmed (CARL) EBITDA (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Carlsmed reported EBITDA of -$38.26 million; for FY2025, it came in at -$30.29 million.

  • Going back by year, EBITDA was -$23.98 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q3 2024.
  • Business Quant data shows CARL's EBITDA at -$9.18 million (Q1 2026), -$9.22 million (Q4 2025) and -$8.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 2.75 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 1.19 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 2.49 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 1.53 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 555.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 1.23 Bn
10 Carlsmed 383.61 Mn -75.98 Mn 14.54 Mn -10.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.91 Mn
Mar 31, 2026 -9.18 Mn
Dec 31, 2025 -9.22 Mn
Sep 30, 2025 -8.95 Mn
Jun 30, 2025 -6.44 Mn
Mar 31, 2025 -5.68 Mn
Dec 31, 2024 -4.66 Mn
Sep 30, 2024 -7.74 Mn
API Access

Carlsmed EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CARL&period=max&api_key=YOUR_API_KEY